Can-Fite BioPharma (NYSE:CANF) Receives New Coverage from An

StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the stock. Can-Fite BioPharma Stock Up 1.8 % Shares of CANF opened at $2.23 on Thursday. Can-Fite BioPharma has a 52 week low of $1.52 and a 52 week […]

Related Keywords

Fite Biopharma , Virtu Financial , Fite Biopharma Ltd , Armistice Capital , Schechter Investment Advisors , Can Fite Biopharma , Free Report , Investment Advisors , Get Free Report , Can Fite Biopharma Daily , Nyse Canf , Ocanf , Medical , Initiated Coverage , Stocknews Com ,